Results 61 to 70 of about 46,954 (256)

Prevalence of Multidrug-Resistant TB Among Smear-Positive Pulmonary TB Patients in Banadir, Somalia: A Multicenter Study

open access: yesInfection and Drug Resistance, 2022
Abdirahman Mohamed Hassan Dirie,1 Sedat Çolakoğlu,1 Osman Muhyadin Abdulle,2 Bashir Mohamud Abdi,3 Mohamed Abdi Osman,4 Abdiaziz Mohamud Shire,5 Abdinafic Mohamud Hussein6 1Pulmonology Department, Somalia Mogadishu Turkey Recep Tayyip Erdogan ...
Dirie AMH   +6 more
doaj  

Whole Genome and Transcriptome Sequencing of Two Multi-Drug Resistant Mycobacterium tuberculosis Strains to Facilitate Illustrating Their Virulence in vivo

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Mycobacterium tuberculosis clinical strains usually possess traits different from the laboratory strains like H37Rv, especially those clinical drug resistant strains.
Jun Tang   +24 more
doaj   +1 more source

Factors Affecting the Success of Multi Drug Resistance (Mdr-Tb) Tuberculosis Treatment in Residential Surakarta [PDF]

open access: yes, 2017
Background: Tuberculosis (TB) is a global public health concern. The new challenge in TB control is the development of TB multi drug resistance (MDR-TB). Indonesia ranks 8th highest in the incidence of MDR-TB with 8,900 MDR-TB cases in 2004.
Probandari, A. N. (Ari)   +9 more
core   +1 more source

MDR-TB updated data.

open access: yes, 2023
BackgroundMultidrug-resistant tuberculosis (MDR-TB) remains a public health emergency and a threat globally. Although increasing MDR-TB cases have been recently reported in Somalia, limited information is known.
Celso José Bruno de Oliveira (11497468)   +10 more
core   +1 more source

Resistance Patterns among Multidrug-Resistant Tuberculosis Patients: A Multi-Center Study from Pakistan

open access: yesInternational Journal of Endorsing Health Science Research, 2017
Background: The high burden of multi-drug resistance tuberculosis (MDR TB) is a matter of great concern. The increasing resistance to anti tuberculosis drugs has been the area of growing concern and are posing threats to TB control.
Rabab Batool   +4 more
doaj   +1 more source

Cross roads in the management of Multi Drug Resistant Tuberculosis (MDR-TB)

open access: yesCurrent Medicine Research and Practice, 2014
MDR-TB is a growing menace and stumbling block to adequate control of TB. Inappropriate treatment regimens, inadequate duration of treatment and non-adherence to treatment are the leading causes for resistance. Therefore MDR-TB can be considered as a result of human errors in management.
Jolsana Augustine, Neeraj Jain
openaire   +1 more source

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop   +3 more
wiley   +1 more source

Pharmacological modulation and manipulation of cancer drug resistance [PDF]

open access: yes, 2010
The aim of this project was to investigate pharmacological methods of overcoming resistance in cancer. Novel compounds, targeted therapies and non-steroidal anti-inflammatory drugs (NSAIDs) were examined for their potential to modulate and manipulate ...
Devery, Aoife
core  

Adverse events in bedaquiline‐ and pretomanid‐based regimens for drug‐resistant tuberculosis from trial, implementation and pharmacovigilance studies

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract The availability of safety data, particularly concerning adverse events (AEs) associated with the new shorter regimen for drug‐resistant tuberculosis (TB) containing a bedaquiline–pretomanid‐based regimen, is still limited. This systematic review aims to provide a comprehensive and updated analysis of AEs related to this new regimen by ...
Nisa Maria   +4 more
wiley   +1 more source

Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis. [PDF]

open access: yes, 2015
BACKGROUND: Owing toGiven the high costs of drugs to treat multi-drug resistant tuberculosis (MDR-TB), the Green Light Committee (GLC) initiative enables TB programs to procure quality-assured drugs at reduced prices.
David Moore   +23 more
core   +1 more source

Home - About - Disclaimer - Privacy